The pattern of pegylated interferon-α2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype

Saved in:
Bibliographic Details
Published inAntiviral therapy Vol. 14; no. 4; pp. 577 - 584
Main Authors Aghemo, Alessio, Rumi, Maria Grazia, Monico, Sara, Prati, Gian Maria, D'Ambrosio, Roberta, Donato, Maria Francesca, Colombo, Massimo
Format Journal Article
LanguageEnglish
Published London International Medical Press 01.05.2009
Subjects
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
Gastroenterology. Liver. Pancreas. Abdomen
Human viral diseases
Infectious diseases
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Medical sciences
Other diseases. Semiology
Pharmacology. Drug treatments
Viral diseases
Viral hepatitis
Antineoplastic agent
Human
Typing
Cytokine
Hepatic disease
Genotype
Patient
Ribavirin
Infection
Virus
Cirrhosis
Treatment
Interferon alpha 2b
Viral disease
Nucleoside analog
Digestive diseases
Antiviral
Flaviviridae
Pegylated form
Hepatitis C virus
Hepacivirus
Failure
Viral hepatitis C
Online AccessGet full text

Cover

More Information
ISSN:1359-6535
2040-2058
DOI:10.1177/135965350901400415